Skip to main content

Correction to: Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells

The Original Article was published on 22 September 2016

Correction to: Journal of Hematology & Oncology (2016) 9:93 https://doi.org/10.1186/s13045-016-0327-5

The original article [1] contains an error in Fig. 4b, the panel of colonies of 5 µM Ara-C treatment was unintentionally duplicated onto the colonies of 2.5 µM alantolactone treatment. The error was mistakenly introduced in image integration when organizing the figures. However, the error has no bearing on the work’s scientific conclusions as the statistical results are based on the correct pictures. The authors apologize to the editor and readership of Journal of Hematology & Oncology for any inconvenience caused.

Fig. 4
figure4

Alantolactone suppressed primary AML but not normal colony formation after 14 days in methocult H4434. a Alantolactone dramatically reduced the number of CFUs in primary AML cells from eight AML specimens with a dose-dependent manner. b The representative microscopy images of CFUs in primary AML cells were shown. c Alantolactone showed little effect on the CFUs in normal hematopoietic cells and Ara-C treatment led to notable reduction of colonies from normal donors. d The representative microscopy images of CFUs in normal hematopoietic cells were shown. *P < 0.05, **P < 0.01, ***P < 0.0001

Reference

  1. 1.

    Ding Y, Gao H, Zhang Y, Li Y, Vasdev N, Gao Y, Chen Y, Zhang Q. Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells. J Hematol Oncol. 2016;9:93.

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Quan Zhang.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ding, Y., Gao, H., Zhang, Y. et al. Correction to: Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells. J Hematol Oncol 14, 61 (2021). https://doi.org/10.1186/s13045-021-01069-3

Download citation